Marathon Nextgen Realty Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 14, 2025, 10:28 am

Market Cap	3,017 Cr.
Current Price	589
High / Low	737/352
Stock P/E	16.2
Book Value	232
Dividend Yield	0.17 %
ROCE	15.1 %
ROE	17.1 %
Face Value	5.00
PEG Ratio	0.26

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Marathon Nextgen Realty Ltd

Competitors of Marathon Nextgen Realty Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Modern Engineering and Projects Ltd	51.3 Cr.	33.2	87.3/22.5	7.04	36.3	0.00 %	21.0 %	26.4 %	10.0
Modis Navnirman Ltd	544 Cr.	278	311/220	44.4	53.6	0.00 %	16.7 %	12.9 %	10.0
Modulex Construction Technologies Ltd	166 Cr.	24.0	35.7/9.28	37.3	43.5	0.00 %	2.24 %	1.54 %	10.0
MPDL Ltd	38.2 Cr.	51.5	92.7/35.8		132	0.00 %	2.87 %	4.16 %	10.0
IITL Projects Ltd	32.8 Cr.	65.7	78.1/34.4		2.97	0.00 %	%	%	10.0
Industry Average	16,024.14 Cr	259.20		32.59	129.34	0.14%	20.04%	27.93%	21.31

All Competitor Stocks of Marathon Nextgen Realty Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	165	98	170	278	170	210	129	210	155	162	146	123	149
Expenses	121	62	134	152	129	149	81	134	108	109	104	87	107
Operating Profit	44	36	36	126	41	61	48	76	47	53	42	36	41
OPM %	27%	37%	21%	45%	24%	29%	37%	36%	30%	33%	29%	30%	28%
Other Income	10	10	12	12	9	10	10	10	11	11	20	26	39
Interest	26	30	31	34	27	25	23	29	14	19	13	9	18
Depreciation	1	1	1	1	1	1	1	1	1	1	1	1	1
Profit before tax	27	15	16	103	22	45	35	57	44	44	49	53	62
Tax %	28%	29%	28%	27%	30%	25%	22%	27%	28%	26%	19%	21%	22%
Net Profit	23	12	16	80	16	43	34	51	40	38	49	49	54
EPS in Rs	5.07	2.46	3.17	17.00	3.50	9.11	7.29	9.80	7.78	7.22	9.46	9.35	10.41

Last Updated: May 31, 2025, 8:28 am

Below is a detailed analysis of the quarterly data for Marathon Nextgen Realty Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 149.00 Cr.. The value appears strong and on an upward trend. It has increased from 123.00 Cr. (Dec 2024) to 149.00 Cr., marking an increase of 26.00 Cr..
For Expenses, as of Mar 2025, the value is 107.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 87.00 Cr. (Dec 2024) to 107.00 Cr., marking an increase of 20.00 Cr..
For Operating Profit, as of Mar 2025, the value is 41.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Dec 2024) to 41.00 Cr., marking an increase of 5.00 Cr..
For OPM %, as of Mar 2025, the value is 28.00%. The value appears to be declining and may need further review. It has decreased from 30.00% (Dec 2024) to 28.00%, marking a decrease of 2.00%.
For Other Income, as of Mar 2025, the value is 39.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Dec 2024) to 39.00 Cr., marking an increase of 13.00 Cr..
For Interest, as of Mar 2025, the value is 18.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.00 Cr. (Dec 2024) to 18.00 Cr., marking an increase of 9.00 Cr..
For Depreciation, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 1.00 Cr..
For Profit before tax, as of Mar 2025, the value is 62.00 Cr.. The value appears strong and on an upward trend. It has increased from 53.00 Cr. (Dec 2024) to 62.00 Cr., marking an increase of 9.00 Cr..
For Tax %, as of Mar 2025, the value is 22.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Dec 2024) to 22.00%, marking an increase of 1.00%.
For Net Profit, as of Mar 2025, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 49.00 Cr. (Dec 2024) to 54.00 Cr., marking an increase of 5.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 10.41. The value appears strong and on an upward trend. It has increased from 9.35 (Dec 2024) to 10.41, marking an increase of 1.06.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: June 15, 2025, 6:56 am

Metric	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	197	193	69	82	241	206	306	717	705	580
Expenses	137	136	26	30	177	142	232	471	472	407
Operating Profit	60	57	43	52	64	64	74	246	233	173
OPM %	31%	29%	62%	63%	27%	31%	24%	34%	33%	30%
Other Income	45	50	1	1	8	18	38	36	41	96
Interest	0	0	5	21	41	44	75	123	91	59
Depreciation	0	0	1	2	6	5	3	3	3	3
Profit before tax	105	106	39	30	26	32	35	156	180	208
Tax %	21%	21%	27%	20%	21%	28%	33%	28%	26%	22%
Net Profit	83	84	39	32	25	16	39	124	169	191
EPS in Rs	14.65	14.79	8.42	6.84	5.23	3.30	8.37	26.12	32.53	36.43
Dividend Payout %	3%	3%	12%	7%	0%	0%	6%	4%	3%	3%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	1.20%	-53.57%	-17.95%	-21.88%	-36.00%	143.75%	217.95%	36.29%	13.02%
Change in YoY Net Profit Growth (%)	0.00%	-54.78%	35.62%	-3.93%	-14.12%	179.75%	74.20%	-181.66%	-23.27%

Marathon Nextgen Realty Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	19%
3 Years:	24%
TTM:	-18%

Compounded Profit Growth
10 Years:	%
5 Years:	51%
3 Years:	69%
TTM:	12%

Stock Price CAGR
10 Years:	27%
5 Years:	64%
3 Years:	46%
1 Year:	16%

Return on Equity
10 Years:	%
5 Years:	14%
3 Years:	18%
Last Year:	17%

Last Updated: Unknown

Balance Sheet

Last Updated: June 12, 2025, 3:06 pm

Month	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	28	28	23	23	23	23	23	23	26	26
Reserves	567	648	527	584	570	586	626	762	970	1,161
Borrowings	0	11	208	429	567	739	1,087	869	761	560
Other Liabilities	8	8	128	461	456	351	402	499	482	350
Total Liabilities	604	696	885	1,497	1,617	1,699	2,139	2,153	2,238	2,097
Fixed Assets	0	0	105	221	294	287	286	283	286	237
CWIP	0	0	0	0	0	0	0	0	0	0
Investments	0	0	14	22	26	13	271	49	81	110
Other Assets	603	695	767	1,255	1,297	1,399	1,582	1,821	1,871	1,750
Total Assets	604	696	885	1,497	1,617	1,699	2,139	2,153	2,238	2,097

Below is a detailed analysis of the balance sheet data for Marathon Nextgen Realty Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 26.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 26.00 Cr..
For Reserves, as of Mar 2025, the value is 1,161.00 Cr.. The value appears strong and on an upward trend. It has increased from 970.00 Cr. (Mar 2024) to 1,161.00 Cr., marking an increase of 191.00 Cr..
For Borrowings, as of Mar 2025, the value is 560.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 761.00 Cr. (Mar 2024) to 560.00 Cr., marking a decrease of 201.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 350.00 Cr.. The value appears to be improving (decreasing). It has decreased from 482.00 Cr. (Mar 2024) to 350.00 Cr., marking a decrease of 132.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 2,097.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,238.00 Cr. (Mar 2024) to 2,097.00 Cr., marking a decrease of 141.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 237.00 Cr.. The value appears to be declining and may need further review. It has decreased from 286.00 Cr. (Mar 2024) to 237.00 Cr., marking a decrease of 49.00 Cr..
For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Investments, as of Mar 2025, the value is 110.00 Cr.. The value appears strong and on an upward trend. It has increased from 81.00 Cr. (Mar 2024) to 110.00 Cr., marking an increase of 29.00 Cr..
For Other Assets, as of Mar 2025, the value is 1,750.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,871.00 Cr. (Mar 2024) to 1,750.00 Cr., marking a decrease of 121.00 Cr..
For Total Assets, as of Mar 2025, the value is 2,097.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,238.00 Cr. (Mar 2024) to 2,097.00 Cr., marking a decrease of 141.00 Cr..

Notably, the Reserves (1,161.00 Cr.) exceed the Borrowings (560.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	-52	-56	169	101	18	-109	76	315	22	-25
Cash from Investing Activity +	64	45	-198	-312	-71	-3	-375	27	112	298
Cash from Financing Activity +	-14	8	40	203	60	144	274	-326	-155	-265
Net Cash Flow	-2	-3	11	-8	7	32	-26	15	-21	8

Free Cash Flow

Month	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	60.00	46.00	-165.00	-377.00	-503.00	-675.00	73.00	-623.00	-528.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	128	497	0	24	33	89	45	22	49
Inventory Days	383	65			12,215	14,683			5,749
Days Payable	4	5			3,492	1,510			460
Cash Conversion Cycle	507	556	0	24	8,756	13,262	45	22	5,338
Working Capital Days	385	558	557	1,347	304	987	675	259	338
ROCE %		17%	6%	6%	6%	6%	7%	17%	16%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	74.97%	74.65%	74.65%	74.44%	74.44%	74.40%	73.45%	73.68%	73.68%	73.63%	73.63%	73.63%
FIIs	0.03%	0.03%	0.07%	0.01%	0.15%	0.24%	2.34%	1.56%	0.56%	0.41%	3.15%	2.34%
DIIs	0.01%	0.12%	0.08%	0.01%	0.03%	0.01%	0.01%	0.07%	0.01%	0.80%	1.61%	2.47%
Government	0.00%	0.00%	2.14%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	24.99%	25.20%	23.06%	25.53%	25.38%	25.35%	24.20%	24.68%	25.75%	25.18%	21.62%	21.57%
No. of Shareholders	7,971	9,151	8,770	7,923	7,582	7,382	10,201	10,330	10,910	9,787	10,635	10,762

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	5.00	5.00	5.00	5.00	5.00
Basic EPS (Rs.)	34.43	26.12	8.37	3.30	5.23
Diluted EPS (Rs.)	32.50	26.12	8.36	3.30	5.23
Cash EPS (Rs.)	26.71	25.03	5.77	6.22	5.71
Book Value[Excl.RevalReserv]/Share (Rs.)	196.85	171.25	142.35	133.51	129.90
Book Value[Incl.RevalReserv]/Share (Rs.)	196.85	171.25	142.35	133.51	129.90
Revenue From Operations / Share (Rs.)	137.70	154.68	66.54	44.68	52.42
PBDIT / Share (Rs.)	53.56	60.82	24.46	17.68	15.79
PBIT / Share (Rs.)	52.98	60.15	23.82	16.50	14.56
PBT / Share (Rs.)	35.21	33.70	7.61	6.98	5.64
Net Profit / Share (Rs.)	26.13	24.35	5.13	5.04	4.47
NP After MI And SOA / Share (Rs.)	32.53	26.12	8.37	3.30	5.23
PBDIT Margin (%)	38.89	39.32	36.76	39.56	30.12
PBIT Margin (%)	38.47	38.88	35.79	36.92	27.76
PBT Margin (%)	25.56	21.78	11.43	15.61	10.75
Net Profit Margin (%)	18.97	15.74	7.70	11.27	8.53
NP After MI And SOA Margin (%)	23.62	16.88	12.58	7.39	9.98
Return on Networth / Equity (%)	16.71	15.40	5.93	2.49	4.05
Return on Capital Employeed (%)	16.11	16.87	6.93	5.76	6.28
Return On Assets (%)	7.43	5.61	1.80	0.89	1.48
Long Term Debt / Equity (X)	0.58	0.99	1.37	1.10	0.73
Total Debt / Equity (X)	0.76	1.11	1.67	1.18	0.87
Asset Turnover Ratio (%)	0.32	0.24	0.09	0.03	0.06
Current Ratio (X)	2.02	2.05	1.77	2.48	1.30
Quick Ratio (X)	0.90	1.02	0.79	1.17	0.36
Dividend Payout Ratio (NP) (%)	2.82	1.90	0.00	0.00	11.51
Dividend Payout Ratio (CP) (%)	2.77	1.86	0.00	0.00	9.31
Earning Retention Ratio (%)	97.18	98.10	0.00	0.00	88.49
Cash Earning Retention Ratio (%)	97.23	98.14	0.00	0.00	90.69
Interest Coverage Ratio (X)	3.01	2.30	1.51	1.86	1.77
Interest Coverage Ratio (Post Tax) (X)	2.47	1.92	1.32	1.53	1.50
Enterprise Value (Cr.)	3295.87	2081.34	1566.87	925.96	660.62
EV / Net Operating Revenue (X)	4.68	2.90	5.12	4.50	2.74
EV / EBITDA (X)	12.03	7.39	13.92	11.39	9.10
MarketCap / Net Operating Revenue (X)	3.71	1.79	1.75	1.38	0.78
Retention Ratios (%)	97.17	98.09	0.00	0.00	88.48
Price / BV (X)	2.63	1.63	0.82	0.46	0.31
Price / Net Operating Revenue (X)	3.71	1.79	1.75	1.38	0.78
EarningsYield	0.06	0.09	0.07	0.05	0.12

After reviewing the key financial ratios for Marathon Nextgen Realty Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
For Basic EPS (Rs.), as of Mar 24, the value is 34.43. This value is within the healthy range. It has increased from 26.12 (Mar 23) to 34.43, marking an increase of 8.31.
For Diluted EPS (Rs.), as of Mar 24, the value is 32.50. This value is within the healthy range. It has increased from 26.12 (Mar 23) to 32.50, marking an increase of 6.38.
For Cash EPS (Rs.), as of Mar 24, the value is 26.71. This value is within the healthy range. It has increased from 25.03 (Mar 23) to 26.71, marking an increase of 1.68.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 196.85. It has increased from 171.25 (Mar 23) to 196.85, marking an increase of 25.60.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 196.85. It has increased from 171.25 (Mar 23) to 196.85, marking an increase of 25.60.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 137.70. It has decreased from 154.68 (Mar 23) to 137.70, marking a decrease of 16.98.
For PBDIT / Share (Rs.), as of Mar 24, the value is 53.56. This value is within the healthy range. It has decreased from 60.82 (Mar 23) to 53.56, marking a decrease of 7.26.
For PBIT / Share (Rs.), as of Mar 24, the value is 52.98. This value is within the healthy range. It has decreased from 60.15 (Mar 23) to 52.98, marking a decrease of 7.17.
For PBT / Share (Rs.), as of Mar 24, the value is 35.21. This value is within the healthy range. It has increased from 33.70 (Mar 23) to 35.21, marking an increase of 1.51.
For Net Profit / Share (Rs.), as of Mar 24, the value is 26.13. This value is within the healthy range. It has increased from 24.35 (Mar 23) to 26.13, marking an increase of 1.78.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 32.53. This value is within the healthy range. It has increased from 26.12 (Mar 23) to 32.53, marking an increase of 6.41.
For PBDIT Margin (%), as of Mar 24, the value is 38.89. This value is within the healthy range. It has decreased from 39.32 (Mar 23) to 38.89, marking a decrease of 0.43.
For PBIT Margin (%), as of Mar 24, the value is 38.47. This value exceeds the healthy maximum of 20. It has decreased from 38.88 (Mar 23) to 38.47, marking a decrease of 0.41.
For PBT Margin (%), as of Mar 24, the value is 25.56. This value is within the healthy range. It has increased from 21.78 (Mar 23) to 25.56, marking an increase of 3.78.
For Net Profit Margin (%), as of Mar 24, the value is 18.97. This value exceeds the healthy maximum of 10. It has increased from 15.74 (Mar 23) to 18.97, marking an increase of 3.23.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 23.62. This value exceeds the healthy maximum of 20. It has increased from 16.88 (Mar 23) to 23.62, marking an increase of 6.74.
For Return on Networth / Equity (%), as of Mar 24, the value is 16.71. This value is within the healthy range. It has increased from 15.40 (Mar 23) to 16.71, marking an increase of 1.31.
For Return on Capital Employeed (%), as of Mar 24, the value is 16.11. This value is within the healthy range. It has decreased from 16.87 (Mar 23) to 16.11, marking a decrease of 0.76.
For Return On Assets (%), as of Mar 24, the value is 7.43. This value is within the healthy range. It has increased from 5.61 (Mar 23) to 7.43, marking an increase of 1.82.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.58. This value is within the healthy range. It has decreased from 0.99 (Mar 23) to 0.58, marking a decrease of 0.41.
For Total Debt / Equity (X), as of Mar 24, the value is 0.76. This value is within the healthy range. It has decreased from 1.11 (Mar 23) to 0.76, marking a decrease of 0.35.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.32. It has increased from 0.24 (Mar 23) to 0.32, marking an increase of 0.08.
For Current Ratio (X), as of Mar 24, the value is 2.02. This value is within the healthy range. It has decreased from 2.05 (Mar 23) to 2.02, marking a decrease of 0.03.
For Quick Ratio (X), as of Mar 24, the value is 0.90. This value is below the healthy minimum of 1. It has decreased from 1.02 (Mar 23) to 0.90, marking a decrease of 0.12.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 2.82. This value is below the healthy minimum of 20. It has increased from 1.90 (Mar 23) to 2.82, marking an increase of 0.92.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 2.77. This value is below the healthy minimum of 20. It has increased from 1.86 (Mar 23) to 2.77, marking an increase of 0.91.
For Earning Retention Ratio (%), as of Mar 24, the value is 97.18. This value exceeds the healthy maximum of 70. It has decreased from 98.10 (Mar 23) to 97.18, marking a decrease of 0.92.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 97.23. This value exceeds the healthy maximum of 70. It has decreased from 98.14 (Mar 23) to 97.23, marking a decrease of 0.91.
For Interest Coverage Ratio (X), as of Mar 24, the value is 3.01. This value is within the healthy range. It has increased from 2.30 (Mar 23) to 3.01, marking an increase of 0.71.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.47. This value is below the healthy minimum of 3. It has increased from 1.92 (Mar 23) to 2.47, marking an increase of 0.55.
For Enterprise Value (Cr.), as of Mar 24, the value is 3,295.87. It has increased from 2,081.34 (Mar 23) to 3,295.87, marking an increase of 1,214.53.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 4.68. This value exceeds the healthy maximum of 3. It has increased from 2.90 (Mar 23) to 4.68, marking an increase of 1.78.
For EV / EBITDA (X), as of Mar 24, the value is 12.03. This value is within the healthy range. It has increased from 7.39 (Mar 23) to 12.03, marking an increase of 4.64.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 3.71. This value exceeds the healthy maximum of 3. It has increased from 1.79 (Mar 23) to 3.71, marking an increase of 1.92.
For Retention Ratios (%), as of Mar 24, the value is 97.17. This value exceeds the healthy maximum of 70. It has decreased from 98.09 (Mar 23) to 97.17, marking a decrease of 0.92.
For Price / BV (X), as of Mar 24, the value is 2.63. This value is within the healthy range. It has increased from 1.63 (Mar 23) to 2.63, marking an increase of 1.00.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 3.71. This value exceeds the healthy maximum of 3. It has increased from 1.79 (Mar 23) to 3.71, marking an increase of 1.92.
For EarningsYield, as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 23) to 0.06, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Marathon Nextgen Realty Ltd as of June 15, 2025 is: 515.02

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 15, 2025, Marathon Nextgen Realty Ltd is Overvalued by 12.56% compared to the current share price 589.00

Intrinsic Value of Marathon Nextgen Realty Ltd as of June 15, 2025 is: 832.56

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 15, 2025, Marathon Nextgen Realty Ltd is Undervalued by 41.35% compared to the current share price 589.00

Last 5 Year EPS CAGR: 61.65%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (700.10 cr) compared to borrowings (523.10 cr), indicating strong financial stability. The company has shown consistent growth in sales (329.60 cr) and profit (91.70 cr) over the years.	The stock has a low average ROCE of 9.00%, which may not be favorable. The stock has a high average Working Capital Days of 451.56, which may not be favorable. The stock has a high average Cash Conversion Cycle of 131.11, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Marathon Nextgen Realty Ltd:
1. Net Profit Margin: 18.97%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 16.11% (Industry Average ROCE: 20.04%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 16.71% (Industry Average ROE: 27.93%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 2.47
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.9
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 16.2 (Industry average Stock P/E: 32.59)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.76
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Marathon Nextgen Realty Ltd. is a Public Limited Listed company incorporated on 13/01/1978 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L65990MH1978PLC020080 and registration number is 020080. Currently Company is involved in the business activities of Activities of head offices; management consultancya ctivities. Company's Total Operating Revenue is Rs. 241.94 Cr. and Equity Capital is Rs. 25.60 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Construction, Contracting & Engineering	Marathon Futurex, Mafatlal Mills Compound, Mumbai Maharashtra 400013	shares@marathonnextgen.com http://www.marathonnextgen.com

Management
Name	Position Held
Mr. Chetan R Shah	Chairman & Managing Director
Mr. Mayur R Shah	Vice Chairman
Mrs. Shailaja C Shah	Director
Mrs. Parul Shah	Independent Director
Mr. Atul Mehta	Independent Director
Mr. Ashwin M Thakker	Independent Director
Mr. Deepak R Shah	Independent Director
Mr. Devendra Shrimankar	Independent Director
Mr. Kaivalya Shah	Director
Mr. Samyag Shah	Director

FAQ

What is the intrinsic value of Marathon Nextgen Realty Ltd?

Marathon Nextgen Realty Ltd's intrinsic value (as of 14 June 2025) is ₹515.02 — 12.56% lower the current market price of 589.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,017 Cr. market cap, FY2025-2026 high/low of ₹737/352, reserves of 1,161 Cr, and liabilities of 2,097 Cr.

What is the Market Cap of Marathon Nextgen Realty Ltd?

The Market Cap of Marathon Nextgen Realty Ltd is 3,017 Cr..

What is the current Stock Price of Marathon Nextgen Realty Ltd as on 14 June 2025?

The current stock price of Marathon Nextgen Realty Ltd as on 14 June 2025 is 589.

What is the High / Low of Marathon Nextgen Realty Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Marathon Nextgen Realty Ltd stocks is ₹737/352.

What is the Stock P/E of Marathon Nextgen Realty Ltd?

The Stock P/E of Marathon Nextgen Realty Ltd is 16.2.

What is the Book Value of Marathon Nextgen Realty Ltd?

The Book Value of Marathon Nextgen Realty Ltd is 232.

What is the Dividend Yield of Marathon Nextgen Realty Ltd?

The Dividend Yield of Marathon Nextgen Realty Ltd is 0.17 %.

What is the ROCE of Marathon Nextgen Realty Ltd?

The ROCE of Marathon Nextgen Realty Ltd is 15.1 %.

What is the ROE of Marathon Nextgen Realty Ltd?

The ROE of Marathon Nextgen Realty Ltd is 17.1 %.

What is the Face Value of Marathon Nextgen Realty Ltd?

The Face Value of Marathon Nextgen Realty Ltd is 5.00.